Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27618640 | 0.93 | NAAA (0.49) | NAAAGAACYP2C9CYP2C19HDAC8 | |
| SCHEMBL27760996 | 0.87 | NAAA (0.51) | NAAAGAACYP2C9CYP2C19HDAC8 | |
| SCHEMBL27782707 | 0.85 | NAAA (0.54) | NAAAHDAC8HDAC6EPHX1 | |
| SCHEMBL27600255 | 0.84 | NAAA (0.56) | NAAAEPHX1 | |
| SCHEMBL27104531 | 0.81 | NAAA (0.41) | NAAAGAACYP2C9CYP2C19HDAC8 | |
| SCHEMBL27639742 | 0.81 | GAA (0.51) | NAAAGAACYP2C9CYP2C19HDAC8 | |
| SCHEMBL8333126 | 0.79 | GAA (0.45) | GAASMN1; SMN2 | |
| SCHEMBL15715059 | 0.79 | GAA (0.49) | NAAAGAACYP2C9CYP2C19LMNA | |
| SCHEMBL24393520 | 0.78 | NAAA (0.57) | NAAAEPHX1 | |
| SCHEMBL9829322 | 0.78 | NAAA (0.45) | NAAAGAACYP2C9CYP2C19HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10562893-B2 | Benzimidazoles derivatives as Tec kinases family inhibitors | GB005, INC. (US) | 2020-02-18 | — | — | US | disclosed |
| CN-103189446-A | Stereocomplex polylactic acid film and resin composition | TEIJIN LTD | 2013-07-03 | — | — | CN | disclosed |
| CN-102268157-A | Polypropylene resin composition | — | 2011-12-07 | — | — | CN | disclosed |
| CN-101568585-B | Novel polyolefin resin composition and molded resin obtained therefrom | NEW JAPAN CHEM CO LTD | 2011-08-10 | — | — | CN | disclosed |
| CN-101568585-A | Novel polyolefin resin composition and molded resin obtained therefrom | NEW JAPAN CHEM CO LTD (JP) | 2009-10-28 | — | — | CN | disclosed |
| CN-100442570-C | Electroluminescent device using metal nano-particles | SAMSUNG SDI CO LTD (KR) | 2008-12-10 | — | — | CN | disclosed |
| CN-1612661-A | Electroluminescent device using metal nano-particles | SAMSUNG SDI CO LTD (KR) | 2005-05-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10562893-B2 | Benzimidazoles derivatives as Tec kinases family inhibitors | BMX, TEC, BTK | NAAA 4538/4885GAA 2332/4885CYP2C9 1754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.